- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antiangiogenic therapy in breast cancer ; volume:10 ; number:4 ; day:6 ; month:11 ; year:2017 ; pages:194-201 ; date:12.2017
Magazine of European Medical Oncology ; 10, Heft 4 (6.11.2017), 194-201, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Gampenrieder, Simon Peter
- Contributor
-
Westphal, Theresa
Greil, Richard
SpringerLink (Online service)
- DOI
-
10.1007/s12254-017-0362-0
- URN
-
urn:nbn:de:1111-201802081840
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gampenrieder, Simon Peter
- Westphal, Theresa
- Greil, Richard
- SpringerLink (Online service)
Other Objects (12)
Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
Antiangiogenic therapy
Antiangiogenic gene therapy of cancer: recent developments
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
Antiangiogenic therapies in ovarian cancer
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer
Characterization of anti-angiogenic therapy response in glioblastoma
18F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts
Antiangiogenic therapy: how far is it to upgrade?
Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
Antiangiogenic therapy
Antiangiogenic gene therapy of cancer: recent developments
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
Antiangiogenic therapies in ovarian cancer
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer
Characterization of anti-angiogenic therapy response in glioblastoma
18F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts
Antiangiogenic therapy: how far is it to upgrade?
Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
Antiangiogenic therapy
Antiangiogenic gene therapy of cancer: recent developments
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
Antiangiogenic therapies in ovarian cancer
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer
Characterization of anti-angiogenic therapy response in glioblastoma
18F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts